DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20203152

Quasispecies pattern in coronavirus along with new concern of recurrence, relapse and re-infection of SARS-CoV-2

Pamayyagari Kalpana

Abstract


Ever since the outbreak of pandemic novel corona virus (severe acute respiratory syndrome corona virus 2 (SARS-CoV-2)), from December 2019, researchers worldwide are working round the clock to identify the drug targets and suitable treatment options. A better knowledge of virus diversification and evolution may be critical in preventing and treating the spread of such pathogenic viruses. This article reviews the evidences available regarding the genome sequence studies of severe acute respiratory syndrome corona virus (SARS-CoV), middle East respiratory syndrome corona virus and SARS-CoV-2 that support the quasispecies nature of virus. Further few concepts of reoccurrence, relapse and reinfection of corona virus were also summarized.


Keywords


COVID 19, Genome sequence, Novel corona virus, Quasispecies, Recurrence, Relapse, Re-infection

Full Text:

PDF

References


World Health Organization, SARS (Severe Acute Respiratory Syndrome). Available at: https://www. who.int/ith/diseases/sars/en/. Accessed on 06 June 2020.

World Health Organization, Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia. Available at: https://www.who.int/csr/don/05-may-2020-mers-saudi-arabia/en/. Accessed on 06 June 2020.

Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cures. 2020;12(4):e7560.

Domingo E, Perales C. Viral Quasispecies. PLOS Genetics. 2019;15(10):e1008271.

Martínez MA, Martrus G, Capel E, Parera M, Franco S, Nevot M. Quasispecies Dynamics of RNA Viruses. Viruses: Essential Agents of Life. 2012: 21-42.

Domingo E, Sheldon J, Perales C. Viral Quasispecies evolution. Microbiol Mol Biol Rev. 2012;76(2):159‐216.

Xu D, Zhang Z, Wang FS. SARS-associated coronavirus Quasispecies in individual patients. N Engl J Med. 2004;350(13):1366-7.

Tang JW, Cheung JL, Chu IM, Sung JJ, Peiris M, Chan PK. The large 386-nt deletion in SARS-associated coronavirus: evidence for Quasispecies? J Infect Dis. 2006;194:808-13.

Briese T, Mishra N, Jain K, Zalmout IS, Jabado OJ, Karesh WB, Daszak P, et al Middle East respiratory syndrome coronavirus Quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. mBio. 2014;5(3):e01146-14.

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9.

Capobianchi MR. Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy, Clinical Microbiology and Infection, Clin Microbiol Infect. 2020;26(7):954-6.

Ranjit Sah et al,Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal. Microbiol Resource Announcements. 2020;9(11):e00169-20.

World health organization, WHO SARS Risk Assessment and Preparedness Framework October 2004. Available at: https://www.who.int/csr/ resources/publications/WHO_CDS_CSR_ARO_2004_2/en/. Accessed on 06 June 2020.

Wong TW. "Will the SARS epidemic recur?" A retrospective analysis of the experts' opinions. J Epidemiol Community Health. 2006;60(1):87.

Tsang OT, Chau TN, Choi KW, Tso EYK, Lim W, Chiu MC, et al. Severe acute respiratory syndrome: Relapse? Hospital infection?. Emerg Infect Dis. 2003;9(9):1180‐1.

Chien JY, Hsueh PR, Chang SC, Hwang JJ, Yu CJ, Yang PC. Relapse of SARS upon tapering corticosteroid. Intensive Care Med. 2004;30(6):1240‐1.

Wu LP, Wang NC, Chang YH, Tian XY, Na DY, Zhang LY, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562‐4.

Alaskar A. Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia Blood. Outcomes Res-Non-Malignant Conditions. 2019;134(1):5871.

Ota M. Will we see protection or reinfection in COVID-19?. Nat Rev Immunol. 2020.

Chen D, Xu W, Lei Z, Liu J, Gao Z, Peng L, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. Int J Infect Dis. 2020;93:297‐9.

Setti L. Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence. Int J Environ Res Public Health. 2020;17(9):2986.